Posted inGenetics
StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A
For years, market watchers have speculated about some biopharma giant or other buying out BioMarin Pharmaceutical (NASDAQ: BMRN), which is…
Posted inGenetics
Malaria Turns Down Genes to Evade Immunity, Enable Chronic Infection
Researchers at Weill Cornell Medicine have discovered how Plasmodium falciparum, the parasite that causes malaria when transmitted through a mosquito…
Posted inGenetics
The Future of Biomanufacturing: AI-Driven Cell Line Development and Bioprocess Design
Broadcast Date: Wednesday, June 25, 2025Time: 8:00 am PT, 11:00 am ET, 17:00 CESTTraditional approaches to biologics production—relying on one-size-fits-all…
Posted inGenetics
3PBIOVIAN Introduces Two Platforms for AAV and pDNA Manufacturing
CDMO 3PBIOVIAN officials report that the company has launched the AAVion® platform, a fully integrated adeno-associated virus (AAV) manufacturing solution…
Posted inGenetics
Biotech and Beignets: The News from Day One of ASGCT
The American Society of Gene and Cell Therapy (ASGCT) meeting is off and running in New Orleans! Kevin Davies, PhD, editorial director…
Posted inGenetics
Immune Cell Type Linked to Oral Tolerance and Childhood Food Allergies
A decade ago, a clinical trial in the U.K. notably showed that children who were exposed to peanuts in the…
Posted inGenetics
New Multi-Species Bat Organoid Platform Enhances Pandemic Preparedness
The world’s largest bat organoid platform, which promises improvement in the study of zoonotic viruses, has been newly developed by…
Posted inGenetics
CAR T-Cell Therapy: New Advances Move On Past Setbacks
Chimeric antigen receptor (CAR) T-cell therapy is an innovative cancer treatment that engineers a patient’s own T cells to target…
Posted inGenetics
Estrogen-Related Receptors Boost Muscle Mitochondria in Mice
We all learned in high school biology that mitochondria are the powerhouse of the cell. But powering up those cellular…
Posted inGenetics
10x Eliminates 8% of Workforce in $50M Cost-Cutting Effort
10x Genomics says it eliminated 8% of its workforce—about 100 jobs—as part of a company effort to cut $50 million…